Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Herpes simplex keratitis.

P S Suresh1, A B Tullo

  • 1Manchester Royal Eye Hospital, UK.

Indian Journal of Ophthalmology
|June 20, 2000
PubMed
Summary
This summary is machine-generated.

Herpes simplex virus (HSV) keratitis causes blindness, but new topical antivirals aid management. Correct diagnosis and avoiding topical steroids are crucial for effective treatment of this chronic eye infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LC-MS/MS determination of tideglusib, a novel GSK-3β inhibitor in mice plasma and its application to a pharmacokinetic study in mice.

Journal of pharmaceutical and biomedical analysis·2017
Same author

Review of HPLC and LC-MS/MS assays for the determination of various nonsteroidal anti-androgens used in the treatment of prostate cancer.

Biomedical chromatography : BMC·2017
Same author

Validated LC-MS-MS Method for Determination of SF0034 in Mice Plasma: Application to a Pharmacokinetic Study in Mice.

Journal of chromatographic science·2017
Same author

Validation of an LC-MS/MS method for simultaneous detection of four HDAC inhibitors - belinostat, panobinostat, rocilinostat and vorinostat in mouse plasma and its application to a mouse pharmacokinetic study.

Biomedical chromatography : BMC·2016
Same author

Review of bioanalytical assays for the quantitation of various HDAC inhibitors such as vorinostat, belinostat, panobinostat, romidepsin and chidamine.

Biomedical chromatography : BMC·2016
Same author

Infusion Rate Dependent Pharmacokinetics of Bendamustine with Altered Formation of γ-hydroxybendamustine (M3) Metabolite Following 30- and 60-min Infusion of Bendamustine in Rats.

Drug research·2016
Same journal

Eye injury rates and community cost savings through vision centers: Evidence from southern India.

Indian journal of ophthalmology·2026
Same journal

Evaluation of the protective efficiency of polycarbonate goggles against firecracker-related ocular injuries.

Indian journal of ophthalmology·2026
Same journal

Comment on: Clinical characteristics, risk factor analysis, and outcomes of graft rejection after Descemet membrane endothelial keratoplasty.

Indian journal of ophthalmology·2026
Same journal

Issue regarding E Log book for PG students: Paper to pixels.

Indian journal of ophthalmology·2026
Same journal

Methylation matters: A case control study on epigenetic alteration in diabetic retinopathy.

Indian journal of ophthalmology·2026
Same journal

Understanding the disconnect: A pilot study of public perception versus reality of corneal donation in India.

Indian journal of ophthalmology·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Virology
  • Infectious Diseases

Background:

  • Herpes simplex virus (HSV) infection is a significant cause of unilateral blindness due to chronic keratitis.
  • Despite advances in understanding HSV at cellular and molecular levels, prevention strategies remain elusive.
  • Topical antiviral agents offer a promising avenue for managing HSV keratitis.

Purpose of the Study:

  • To review the virological and clinical aspects of HSV keratitis.
  • To discuss current concepts in the pathogenesis of HSV keratitis.
  • To outline contemporary management strategies for HSV keratitis.

Main Methods:

  • Review of virological data related to HSV keratitis.
  • Analysis of clinical presentations and diagnostic criteria for HSV keratitis.

Related Experiment Videos

  • Evaluation of current treatment guidelines and therapeutic options for HSV keratitis.

    • Main Results:

    • HSV keratitis remains a leading cause of preventable blindness worldwide.
    • Non-toxic topical antiviral medications represent a significant advancement in managing HSV keratitis.
    • Appropriate diagnosis and judicious use of treatments, particularly avoiding inappropriate topical steroid use, are critical.

    Conclusions:

    • Effective management of HSV keratitis hinges on accurate diagnosis and appropriate antiviral therapy.
    • Avoiding the misuse of topical steroids is paramount to prevent complications and vision loss.
    • Continued research into HSV pathogenesis may lead to future preventative measures.